Subtle changes in ADMA and L-arginine concentrations in normal pregnancies are unlikely to account for pregnancy-related increased flow-mediated dilatation

Clinical Physiology and Functional Imaging

Volumn 28, Issue 2, 2008, Pages 120-124

  Saarelainen, Heli ^a   Valtonen, Pirjo ^a   Punnonen, Kari ^a   Laitinen, Tomi ^a   Raitakari, Olli T ^b   Juonala, Markus ^b   Heiskanen, Nonna ^a   Lyyra Laitinen, Tiina ^a   Viikari, Jorma S A ^b   Vanninen, Esko ^a   Heinonen, Seppo ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Asymmetric dimethylarginine; Flow mediated dilation; L arginine; Pregnancy

Indexed keywords

ARGININE; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; TRIACYLGLYCEROL;

ADULT; AGE; AMINO ACID BLOOD LEVEL; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; FEMALE; FINLAND; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

ADULT; ARGININE; BLOOD FLOW VELOCITY; BLOOD GLUCOSE; BRACHIAL ARTERY; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FINLAND; HUMANS; LIPIDS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; VASODILATION;

EID: 39049141542     PISSN: 14750961     EISSN: 1475097X     Source Type: Journal    
DOI: 10.1111/j.1475-097X.2007.00784.x     Document Type: Article

References (27)

1. Abbasi F, Asagmi T, Cooke JP, Lamendola C, McLaughlin T, Reaven GM, Stuehlinger M, Tsao PS. Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus. Am J Cardiol (2001); 88: 1201-1203.
2. Altman DG. Practical Statistics for Medical Research - Chap. 15, Clinical Trials (1996), pp. 440-476. Chapman & Hall, London.
3. Böger RH, Bode-Böger SM, Szuba A, Tsao PS, Chan JR, Thangphao O, Blaschke TF, Cooke JP. ADMA: A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation (1998); 98: 1842-1847.
4. Butte NF. Carbohydrate and lipid metabolism in pregnancy: Normal compared with gestational diabetes mellitus. Am J Clin Nutr (2000); 71: 1256S-1261S.
5. Cockell AP, Poston L. Flow mediated vasodilation is enhanced in normal pregnancy but reduced in pre-eclampsia. Hypertension (1997); 30: 247-251.
6. Dørup I, Skajaa K, Sørensen KE. Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilatation. Am J Physiol Heart Circ Physiol (1999); 276: 821-825.
7. Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and preeclampsia. Am J Obstet Gynecol (1998); 178: 551-556.
8. Juonala M, Viikari JSA, Hutri-Kähönen N, Pietikäinen M, Jokinen E, Taittonen L, Marniemi J, Rönnemaa T, Raitakri OT. The 21-year follow-up of the Cardiovascular Risk in Young Finns Study: Risk factor levels, secular trends and east-west difference. J Intern Med (2004); 255: 457-468.
9. Juonala M, Viikari JSA, Alfthan G, Kähönen M, Taittonen L, Laitinen T, Raitakari OT. Asymmetrical dimethylarginine is inversely associated with brachial flow-mediated dilation in young adults. The Cardiovascular Risk in Young Finns Study. Circulation (2007); 116: 1367-1373.
10. Kielstein JT, Bode-Böger SM, Hesse G, Martens-Lobenhoffer J, Takacs A, Fliser D, Hoeper MM. Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Arterioscler Thromb Vasc Biol (2005); 25: 1414-1418.
11. Leiper J, Vallance P. Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res (1999); 43: 542-548.
12. Leiper JM, Santa Maria J, Chubb A, MacAllister RJ, Charles IG, Whitley GS, Vallance P. Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deaminases. Biochem J (1999); 343: 209-214.
13. Lundman P, Eriksson MJ, Stühlinger M, Cooke JP, Hamsten A, Tornvall P. Mild-to-moderate hypertriglyceridemia in young men is associated with endothelial dysfunction and increased plasma concentrations of asymmetric dimethylarginine. J Am Coll Cardiol (2001); 38: 111-116.
14. Maas R, Böger RH, Schwedhelm E, Casas JP, López-Jaramillo P, Serrano N, Diaz LA. Plasma concentrations of asymmetric dimethylarginine (ADMA) in Colombian women with pre-eclampsia. Research Letter. JAMA (2004); 291: 823-824.
15. Maeda T, Yoshimura T, Okamura H. Asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, in maternal and fetal circulation. J Soc Gynecol Investig (2003); 10: 2-4.
16. Masuda H, Goto M, Tamaoki S, Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycemia. Br J Pharmacol (1999); 126: 211-218.
17. Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo C, Remuzzi G. l-arginine depletion in preeclampsia orients nitric oxide synthase towards oxidant species. Hypertension (2004); 43: 614-622.
18. Ogawa T, Kimoto M, Sasaoka K. Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylhydrolase, from rat kidney. J Biol Chem (1989); 264: 10205-10209.
19. Petterson A, Hedner T, Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in pre-eclampsia. Acta Obstet Gynecol Scand (1998); 77: 808-813.
20. Rytlewski K, Olszanecki R, Korbut R, Zdebski Z. Effects of prolonged oral supplementation with l-arginine on blood pressure and nitric oxide synthesis in preeclampsia. Eur J Clin Invest (2005); 35: 32-37.
21. Saarelainen H, Laitinen T, Raitakari OT, Juonala M, Heiskanen N, Lyyra-Laitinen T, Viikari JS, Vanninen E, Heinonen S. Pregnancy-related hyperlipidemia and endothelial function in healthy women. Circ J (2006); 70: 768-772.
22. Saitoh M, Osanai T, Kamada T, Matsunaga T, Ishizaka H, Hanada H, Okumura K. High plasma level of asymmetric dimethylarginine in patients with acutely exacerbated congestive heart failure: Role in reduction of plasma nitric oxide level. Heart Vessels (2003); 18: 177-182.
23. Savvidou MD, Hingorani AD, Tsikas D, Frölich JC, Vallance P, Nicolaides KH. Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet (2003); 361: 1511-1517.
24. Teerlink T, Nijveldt RJ, de Jong S, van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem (2002); 303: 131-137.
25. Thornburg KL, Jacobson SL, Giraud GD, Morton MJ. Hemodynamic changes in pregnancy. Semin Perinatol (2000); 24: 11-14.
26. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992); 7: 572-575.
27. Valtonen P, Karppi J, Nyyssönen K, Valkonen VP, Halonen T, Punnonen K. Comparison of HPLC method and commercial ELISA assay for asymmetric dimethylarginine (ADMA) determination in human serum. J Chromatogr B Analyst Technol Biomed (2005); 828: 97-102.